lobbying_activities: 1272559

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1272559	c272b597-d709-4045-83d1-91ffd553308e	Q2	CONSUMER HEALTHCARE PRODUCTS ASSOCIATION	29403	CONSUMER HEALTHCARE PRODUCTS ASSOCIATION	2012	second_quarter	PHA	Over-the-Counter (OTC) medicines; Manufacturing and importation of OTC drugs; mandatory recall authority of the FDA; Rx-to-OTC Switch H.R. 1483 - Drug Safety Enhancement Act of 2011. Amends the federal Food, Drug, and Cosmetic Act (FDCA) to expand drug establishment registration requirements to include foreign drug establishments and other purposes; all sections. S. 1584 - Drug Safety and Accountability Act of 2011. Amends the federal Food, Drug, and Cosmetic Act (FDCA) to expand registration requirements for drug manufacturers, wholesalers, distributors, and retailers; grants FDA mandatory recall authority; requires adequate documentation of the pharmaceutical supply chain; all sections. House and Senate drafts of Prescription Drug User Fee Act (PDUFA). Reauthorizes the Food and Drug Administration (FDA) to collect user fees from pharmaceutical on over-the-counter drug manufacturers; all sections (H.R. 5651/S. 3187).	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE		183564	0	0	2012-07-19T09:46:30.007000-04:00